Efficacy and Safety of Rivastigmine in Patients With Mild Cognitive Impairment

This study has been terminated.

(The Principal Investigator left the clinic and there was no one who could take over this study.)

Sponsor:

Information provided by:

Novartis

ClinicalTrials.gov Identifier:

NCT00134953

First received: August 23, 2005

Last updated: December 14, 2007

Last verified: December 2007

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been terminated.
Study Completion Date:	May 2004
Estimated Primary Completion Date:	No date given